Tocotrienols are good adjuvants for developing cancer vaccines
/in Dendritic Cells, International Publications /von 2010-01-06 / BMC Cancer 2010 Jan;10:5Personalized dendritic cell-based tumor immunotherapy
/in Dendritic Cells, International Publications /von 2010-01-01 / Immunotherapy 2010 Jan;2(1):57-68Clinical applications of a peptide-based vaccine for glioblastoma
/in Dendritic Cells, Glioblastoma, International Publications /von 2010-01-01 / Neurosurg. Clin. N. Am. 2010 Jan;21(1):95-109Dendritic cell vaccines for brain tumors
/in Dendritic Cells, Glioblastoma, International Publications /von 2010-01-01 / Neurosurg. Clin. N. Am. 2010 Jan;21(1):139-57Generation of myeloma-specific T cells using dendritic cells loaded with MUC1- and hTERT- drived nonapeptides or myeloma cell apoptotic bodies
/in Dendritic Cells, International Publications, Multiple Myeloma /von 2010-01-01 / Neoplasma 2010;57(5):455-64Tumor antigen presentation by dendritic cells
/in Dendritic Cells, International Publications /von 2010-01-01 / Crit. Rev. Immunol. 2010;30(4):345-86Identification of a microRNA signature in dendritic cell vaccines for cancer immunotherapy
/in Dendritic Cells, International Publications /von 2010-01-01 / Hum. Immunol. 2010 Jan;71(1):67-73Heat shock proteins in glioblastomas
/in Dendritic Cells, Glioblastoma, Hyperthermia, International Publications /von 2010-01-01 / Neurosurg. Clin. N. Am. 2010 Jan;21(1):111-23Towards a standardized protocol for the generation of monocyte-derived dendritic cell vaccines
/in Dendritic Cells, International Publications /von 2010-01-01 / Methods Mol. Biol. 2010;595:149-63
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de